SCHEMBL4450097

SCHEMBL4450097

CCCCOC(=O)c1cccc(OC)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.67
MEN1 O00255 1/20 0.67
KMT2A Q03164 1/20 0.67
GAA P10253 1/20 0.60
MAPT P10636 1/20 0.60
NPSR1 Q6W5P4 1/20 0.59
CES2 O00748 1/20 0.56
CES1 P23141 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.55
CYP1A2 P05177 3/20 0.54
CYP2C19 P33261 3/20 0.54
CYP2C9 P11712 2/20 0.54
NPC1 O15118 1/20 0.54
HPGD P15428 1/20 0.54
RAB9A P51151 1/20 0.54
ESR1 P03372 4/20 0.54
TSHR P16473 3/20 0.54
LMNA P02545 2/20 0.54
CYP2D6 P10635 1/20 0.54
MAPK1 P28482 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22497787 0.95 MEN1 (0.65) SMN1; SMN2MEN1KMT2AGAAMAPT
Methane SCHEMBL29016050 0.94 MEN1 (0.64) SMN1; SMN2MEN1KMT2AGAAMAPT
SCHEMBL27924933 0.94 MEN1 (0.64) SMN1; SMN2MEN1KMT2AGAAMAPT
SCHEMBL22498355 0.94 MEN1 (0.64) SMN1; SMN2MEN1KMT2AGAAMAPT
SCHEMBL8457667 0.94 MEN1 (0.64) SMN1; SMN2MEN1KMT2AGAAMAPT
SCHEMBL11245249 0.94 MEN1 (0.64) SMN1; SMN2MEN1KMT2AGAAMAPT
SCHEMBL8458602 0.94 MEN1 (0.64) SMN1; SMN2MEN1KMT2AGAAMAPT
SCHEMBL11505600 0.91 SMN1; SMN2 (0.70) SMN1; SMN2MEN1KMT2AGAAMAPT
SCHEMBL17961071 0.89 KMT2A (0.60) SMN1; SMN2KMT2AL3MBTL1CYP1A2CYP2C19
SCHEMBL111861 0.87 L3MBTL1 (0.64) SMN1; SMN2L3MBTL1CYP1A2CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3946240-B1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL HENKEL AG & CO KGAA (DE) 2025-10-15 EP claimed
US-20220211602-A1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL HENKEL AG & CO. KGAA (DE) 2022-07-07 US claimed
CN-113677319-A Increasing the stability of agents for treating keratin materials 汉高股份有限及两合公司 2021-11-19 CN claimed
CN-109096420-B Catalyst for olefin polymerization and olefin polymerization method 中国石油化工股份有限公司 2021-05-11 CN claimed
CN-109096424-A A kind of catalyst and olefine polymerizing process for olefinic polymerization 中国石油化工股份有限公司 2018-12-28 CN claimed
CN-109096425-A A kind of catalyst and olefine polymerizing process for olefinic polymerization 中国石油化工股份有限公司 2018-12-28 CN claimed
CN-109096417-A A kind of catalyst and olefine polymerizing process for olefinic polymerization 中国石油化工股份有限公司 2018-12-28 CN claimed
CN-109096420-A A kind of catalyst and olefine polymerizing process for olefinic polymerization 中国石油化工股份有限公司 2018-12-28 CN claimed
CN-109096418-A A kind of catalyst and olefine polymerizing process for olefinic polymerization 中国石油化工股份有限公司 2018-12-28 CN claimed
CN-109096421-A A kind of catalyst and olefine polymerizing process for olefinic polymerization 中国石油化工股份有限公司 2018-12-28 CN claimed
CN-109096419-A A kind of catalyst and olefine polymerizing process for olefinic polymerization 中国石油化工股份有限公司 2018-12-28 CN claimed
CN-102834420-B Internal and external donor compounds for olefin polymerization catalysts ii BASF CORP. (US) 2014-10-22 CN claimed
US-8569195-B2 Internal and external donor compounds for olefin polymerization catalysts II BASF CORPORATION (US) 2013-10-29 US claimed
CN-102834420-A Internal and external donor compounds for olefin polymerization catalysts ii BASF CORP 2012-12-19 CN claimed
CN-112778199-B Compound containing nitrate functional group and synthetic method thereof 南京理工大学 2022-12-13 CN disclosed
US-20220211602-A1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL HENKEL AG & CO. KGAA (DE) 2022-07-07 US disclosed
EP-3946240-A1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL Henkel AG & Co. KGaA (DE) 2022-02-09 EP disclosed
EP-1717607-A1 OPTICAL RESIN LENS AND METHOD FOR PRODUCING OPTICAL RESIN MATERIAL Konica Minolta Opto, Inc. (JP) 2006-11-02 EP disclosed
US-4507450-A COORDINATION CATALYSTS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1985-03-26 US disclosed
US-4229558-A HAVING HIGH ISOTACTIC INDEX BY USING A CATALYST PREPARED FROM A MAGNESIUM GRIGNARD REAGENT, TITANIUM HALIDE AN ETHER AND A CARBOXYLIC ESTER COMBINED WITH AN ORGANOALUMINUM COMPOUND MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1980-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220211602-A1 INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL KRT18, CCNA1, CCNA2 SMN1; SMN2 2729/4885MEN1 535/4885KMT2A 519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.